Search Results 11-20 of 16569 for GLP-1 receptor agonists

1. Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in Type 1 and Type 2 Diabetes - Mayo Clinic

   Prior use of GLP-1 receptor agonists in the previous year. Active systemic illness or malignancy. Symptomatic macrovascular or microvascular disease. Note ...

2. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

   * Patients with T2DM on GLP-1RAs, amylin agonists/analogs (e.g. pramlintide), insulin, sulfonylureas (all due to risk of hypoglycemia with semaglutide or ...

3. Why gastroenterologists and hepatologists should be involved in treating obesity - Mayo Clinic

   Meta-analyses suggest that the GLP-1 agents SQ semaglutide and liraglutide perform well in this role. GLP-1 agonists are associated with an increased risk ...

4. Using technology to remove barriers to bariatric surgery - Mayo Clinic

   Interest and demand for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) continue to rise, leaving fewer people choosing bariatric surgery for weight loss.

5. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide injection is ...

6. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Liraglutide injection is also used together with a reduced-calorie diet and proper exercise ...

7. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

   ... GLP1 Agonist and GLP-1/ GIP agonist medications. ... It is proposed that participants will wear the devices for a period of 28 days before the initiation of GLP-1 ...

8. Semaglutide (oral route) - Side effects & dosage - Mayo Clinic

   Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is also used together with diet and exercise to help lose weight and keep the ...

9. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

   Incretin mimetic (GLP-1 receptor agonists). Medications. Dulaglutide ... Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist ...

10. Prescription weight-loss drugs - Mayo Clinic

    Proprotein subtilisin-kexin type 1 deficiency. Leptin receptor deficiency. ... FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food ...